Corporate News 07-May-21
Board of Caplin Point Laboratories recommends interim dividend
Of Rs 1.5 per share
Caplin Point Laboratories announced that the Board of Directors of the Company at its meeting held on 6 May 2021, inter alia, have recommended the interim dividend of Rs 1.5 per equity Share (i.e. 75%) , subject to the approval of the shareholders.
Previous News
Caplin Point Laboratories to convene board meeting
( Corporate News - 01-Aug-24 11:05 )
Volumes jump at Caplin Point Laboratories Ltd counter
( Hot Pursuit - 01-Oct-24 14:30 )
Caplin Point rises on USFDA nod for eye drops
( Hot Pursuit - 16-Apr-24 11:02 )
Caplin Point climbs on committing Rs 700-cr investment in Tamil Nadu
( Hot Pursuit - 09-Jan-24 14:18 )
Caplin Point arm commences operations at Oncology facility in Chennai
( Hot Pursuit - 27-Mar-24 13:47 )
Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%
( Corporate News - 16-Apr-24 11:32 )
Caplin Point Laboratories announces board meeting date
( Corporate News - 10-May-24 11:22 )
Caplin Point's subsidiary gets US FDA approval for blood pressure restoration drug
( Hot Pursuit - 20-Sep-23 11:11 )
Gland Pharma Ltd leads gainers in 'A' group
( Hot Pursuit - 08-Aug-23 12:00 )
Caplin Point Laboratories to hold board meeting
( Corporate News - 01-Aug-23 12:57 )
Caplin Point Laboratories director resigns
( Corporate News - 12-Jul-22 10:46 )
Other Stories
Vishwaraj Sugar Industries to hold board meeting
14-Jan-25 13:44
MPF Systems to convene board meeting
14-Jan-25 13:43
Indian Railway Finance Corp. to discuss results
14-Jan-25 13:43
Waaree Renewable Techs. to discuss results
14-Jan-25 13:43
Prerna Infrabuild to conduct EGM
14-Jan-25 13:43
Ester Industries grants 1.43 lakh stock options
14-Jan-25 13:12
5Paisa Capital appoints CEO
14-Jan-25 13:10
Fischer Medical Ventures' arm receives CDSCO license to manufacture MRI systems
14-Jan-25 13:07
HDFC Asset Management Company grants 7,500 stock options under ESOS
14-Jan-25 13:04
Colinz Laboratories to announce Quarterly Result
14-Jan-25 12:59
Back
Top